よむ、つかう、まなぶ。
「日本人の食事摂取基準（2025年版）」策定検討会報告書 (438 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_44138.html |
| 出典情報 | 「日本人の食事摂取基準（2025年版）」策定検討会報告書（10／11）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
does not significantly lower total plasma cholesterol concentrations in normal males. Am J Clin Nutr.
1992;55(3):675-681.
18) Wardlaw GM, Snook JT. Effect of diets high in butter, corn oil, or high-oleic acid sunflower oil on serum
lipids and apolipoproteins in men. Am J Clin Nutr. 1990;51(5):815-821.
19) Temme EH, Mensink RP, Hornstra G. Comparison of the effects of diets enriched in lauric, palmitic, or
oleic acids on serum lipids and lipoproteins in healthy women and men. Am J Clin Nutr. 1996;63(6):897-903.
20) Nakamura Y, Okuda N, Turin TC, et al. Fatty acids intakes and serum lipid profiles: NIPPON DATA90 and
the national nutrition monitoring. J Epidemiol. 2010;20(Suppl 3):S544-8.
21) Guo Z, Miura K, Turin TC, et al. Relationship of the polyunsaturated to saturated fatty acid ratio to
cardiovascular risk factors and metabolic syndrome in Japanese: the INTERLIPID study. J Atheroscler
Thromb. 2010;17(8):777-784.
22) Howell WH, McNamara DJ, Tosca MA, et al. Plasma lipid and lipoprotein responses to dietary fat and
cholesterol: a meta-analysis. Am J Clin Nutr. 1997;65(6):1747-1764.
23) Farvid MS, Ding M, Pan A, et al. Dietary linoleic acid and risk of coronary heart disease: a systematic
review and meta-analysis of prospective cohort studies. Circulation. 2014;130(18):1568-1578.
24) Chowdhury R, Warnakula S, Kunutsor S, et al. Association of dietary, circulating, and supplement fatty
acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med. 2014;160(6):398-406.
25) Zhuang P, Zhang Y, He W, et al. Dietary fats in relation to total and cause-specific mortality in a prospective
cohort of 521 120 individuals with 16 years of follow-up. Circ Res. 2019;124(5):757-768.
26) Eslick GD, Howe PRC, Smith C, et al. Benefits of fish oil supplementation in hyperlipidemia: a systematic
review and meta-analysis. Int J Cardiol. 2009;136(1):4-16.
27) Hartweg J, Farmer AJ, Perera R, et al. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on
lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes.
Diabetologia. 2007;50(8):1593-1602.
28) Abdelhamid AS, Brown TJ, Brainard JS, et al. Omega-3 fatty acids for the primary and secondary prevention
of cardiovascular disease. Cochrane Database Syst Rev. 2020;3(3):CD003177.
29) Leslie MA, Cohen DJA, Liddle DM, et al. A review of the effect of omega-3 polyunsaturated fatty acids on
blood triacylglycerol levels in normolipidemic and borderline hyperlipidemic individuals. Lipids Health Dis.
2015;14(1):53.
30) Balk EM, Lichtenstein AH, Chung M, et al. Effects of omega-3 fatty acids on serum markers of
cardiovascular disease risk: a systematic review. Atherosclerosis. 2006;189(1):19-30.
31) Agren JJ, Hänninen O, Julkunen A, et al. Fish diet, fish oil and docosahexaenoic acid rich oil lower fasting
and postprandial plasma lipid levels. Eur J Clin Nutr. 1996;50(11):765-771.
32) Wendland E, Farmer A, Glasziou P, et al. Effect of alpha linolenic acid on cardiovascular risk markers: a
systematic review. Heart. 2006;92(2):166-169.
33) Kotwal S, Jun M, Sullivan D, et al. Omega 3 Fatty acids and cardiovascular outcomes: systematic review
and meta-analysis. Circ Cardiovasc Qual Outcomes. 2012;5(6):808-818.
34) Balk EM, Adams GP, Langberg V, et al. Omega-3 fatty acids and cardiovascular disease: An updated
systematic review. Evid Rep Technol Assess (Full Rep). 2016;(223):1-1252.
35) Aung T, Halsey J, Kromhout D, et al. Associations of omega-3 fatty acid supplement use with cardiovascular
428
1992;55(3):675-681.
18) Wardlaw GM, Snook JT. Effect of diets high in butter, corn oil, or high-oleic acid sunflower oil on serum
lipids and apolipoproteins in men. Am J Clin Nutr. 1990;51(5):815-821.
19) Temme EH, Mensink RP, Hornstra G. Comparison of the effects of diets enriched in lauric, palmitic, or
oleic acids on serum lipids and lipoproteins in healthy women and men. Am J Clin Nutr. 1996;63(6):897-903.
20) Nakamura Y, Okuda N, Turin TC, et al. Fatty acids intakes and serum lipid profiles: NIPPON DATA90 and
the national nutrition monitoring. J Epidemiol. 2010;20(Suppl 3):S544-8.
21) Guo Z, Miura K, Turin TC, et al. Relationship of the polyunsaturated to saturated fatty acid ratio to
cardiovascular risk factors and metabolic syndrome in Japanese: the INTERLIPID study. J Atheroscler
Thromb. 2010;17(8):777-784.
22) Howell WH, McNamara DJ, Tosca MA, et al. Plasma lipid and lipoprotein responses to dietary fat and
cholesterol: a meta-analysis. Am J Clin Nutr. 1997;65(6):1747-1764.
23) Farvid MS, Ding M, Pan A, et al. Dietary linoleic acid and risk of coronary heart disease: a systematic
review and meta-analysis of prospective cohort studies. Circulation. 2014;130(18):1568-1578.
24) Chowdhury R, Warnakula S, Kunutsor S, et al. Association of dietary, circulating, and supplement fatty
acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med. 2014;160(6):398-406.
25) Zhuang P, Zhang Y, He W, et al. Dietary fats in relation to total and cause-specific mortality in a prospective
cohort of 521 120 individuals with 16 years of follow-up. Circ Res. 2019;124(5):757-768.
26) Eslick GD, Howe PRC, Smith C, et al. Benefits of fish oil supplementation in hyperlipidemia: a systematic
review and meta-analysis. Int J Cardiol. 2009;136(1):4-16.
27) Hartweg J, Farmer AJ, Perera R, et al. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on
lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes.
Diabetologia. 2007;50(8):1593-1602.
28) Abdelhamid AS, Brown TJ, Brainard JS, et al. Omega-3 fatty acids for the primary and secondary prevention
of cardiovascular disease. Cochrane Database Syst Rev. 2020;3(3):CD003177.
29) Leslie MA, Cohen DJA, Liddle DM, et al. A review of the effect of omega-3 polyunsaturated fatty acids on
blood triacylglycerol levels in normolipidemic and borderline hyperlipidemic individuals. Lipids Health Dis.
2015;14(1):53.
30) Balk EM, Lichtenstein AH, Chung M, et al. Effects of omega-3 fatty acids on serum markers of
cardiovascular disease risk: a systematic review. Atherosclerosis. 2006;189(1):19-30.
31) Agren JJ, Hänninen O, Julkunen A, et al. Fish diet, fish oil and docosahexaenoic acid rich oil lower fasting
and postprandial plasma lipid levels. Eur J Clin Nutr. 1996;50(11):765-771.
32) Wendland E, Farmer A, Glasziou P, et al. Effect of alpha linolenic acid on cardiovascular risk markers: a
systematic review. Heart. 2006;92(2):166-169.
33) Kotwal S, Jun M, Sullivan D, et al. Omega 3 Fatty acids and cardiovascular outcomes: systematic review
and meta-analysis. Circ Cardiovasc Qual Outcomes. 2012;5(6):808-818.
34) Balk EM, Adams GP, Langberg V, et al. Omega-3 fatty acids and cardiovascular disease: An updated
systematic review. Evid Rep Technol Assess (Full Rep). 2016;(223):1-1252.
35) Aung T, Halsey J, Kromhout D, et al. Associations of omega-3 fatty acid supplement use with cardiovascular
428